AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)
Status:
Recruiting
Trial end date:
2028-10-01
Target enrollment:
Participant gender:
Summary
There has no evidence for the anticoagulation in patients who had undergone catheter ablation
of atrial fibrillation, and has maintained sinus rhythm for more than 1 year. However,
anticoagulation can increase the risk of bleeding, the study evaluating the role of oral
anticoagulation is needed in this patients. This study will compare the efficacy and safety
of non-vitamin K anticoagulants (apixaban) and no oral anticoagulation in patient with sinus
rhythm one year after catheter ablation of AF.